Mirabella Financial Services’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-74,065
| Closed | -$86.7K | – | 506 |
|
|
2022
Q4 | $86.7K | Buy |
+74,065
| New | +$86.7K | 0.01% | 350 |
|
|
2022
Q2 | – | Sell |
-18,800
| Closed | -$29K | – | 606 |
|
|
2022
Q1 | $29K | Buy |
+18,800
| New | +$29K | ﹤0.01% | 508 |
|
|
2021
Q1 | – | Sell |
-61,655
| Closed | -$109K | – | 355 |
|
|
2020
Q4 | $109K | Buy |
+61,655
| New | +$109K | 0.01% | 272 |
|